No profile data available.
Pfizer Inc. (PFE) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in New York, United States, with about 75,000 full-time employees.
It reported revenue of $62.58 billion for fiscal year 2025, down 1.6% from fiscal year 2024, and net income of $7.77 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $15.03 billion, up 2.6% from a year before. Its largest business segment, Global Biopharmaceuticals Business, brought in 98% of segment revenue in fiscal year 2025; United States was the largest region with 59%. Its market capitalization was $161.19 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite.
Pfizer reported $62.58 billion in revenue for fiscal year 2025, down 1.6% from $63.63 billion in fiscal year 2024. In Q2 2026 revenue was $15.03 billion.
Global Biopharmaceuticals Business, with $61.20 billion or 98% of segment revenue in fiscal year 2025. Next: Pfizer Centreone (2%) and Pfizer Ignite (under 1%).
United States: 59% of revenue by region in fiscal year 2025, followed by Developed Markets (26%).
$161.19 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Novartis AG (NVS), AstraZeneca PLC (AZN), Amgen Inc. (AMGN), Sanofi (SNY).